Picton Mahoney Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-228
| Closed | -$1K | – | 935 |
|
|
2025
Q1 | $1K | Sell |
228
-7,059
| -97% | -$31K | ﹤0.01% | 667 |
|
|
2024
Q4 | $24K | Buy |
7,287
+3,365
| +86% | +$11.1K | ﹤0.01% | 491 |
|
|
2024
Q3 | $15K | Buy |
3,922
+3,843
| +4,865% | +$14.7K | ﹤0.01% | 484 |
|
|
2024
Q2 | $1K | Buy |
+79
| New | +$1K | ﹤0.01% | 553 |
|
|
2015
Q2 | – | Sell |
-3,200
| Closed | -$56K | – | 277 |
|
|
2015
Q1 | $56K | Buy |
+3,200
| New | +$56K | ﹤0.01% | 267 |
|